摘要
宫颈癌是第二大妇科恶性肿瘤,威胁到全世界妇女的健康。然而,已报道的治疗宫颈癌的疗效少有改善,因其复发和转移模式。作为一种内源性抗肿瘤剂,色素上皮细胞衍生因子(PEDF)引起了广泛的关注,其对雌激素的敏感性表明其在女性肿瘤(包括宫颈癌)的特殊作用。这篇综述的目的是总结最近的发现,PEDF在宫颈癌治疗中的作用,和增进目前对PEDF抑制血管生成和转移的抗肿瘤特性的了解,包括诱导肿瘤细胞凋亡和分化,及调节细胞免疫预防宫颈癌。PEDF的生产和投递,以及衍生的短肽及其受体也将被讨论。
关键词: 宫颈癌,色素上皮细胞衍生因子,血管生成,分化,凋亡,免疫,转移.
Current Molecular Medicine
Title:Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment
Volume: 15 Issue: 5
Author(s): J. Han and J. Guo
Affiliation:
关键词: 宫颈癌,色素上皮细胞衍生因子,血管生成,分化,凋亡,免疫,转移.
摘要: Cervical cancer is the second leading gynecological malignancy threat to the health of women in the world. However, few improvements in the efficacy of treatments of cervical cancer have been reported for the recurrent and metastasis patterns. As an endogenous antitumor agent, pigment epithelium derived factor (PEDF) has attracted wide attention, and its sensitivity to estrogen suggests a special role in female tumors, including cervical cancer. This review aims to summarize recent findings, the role of PEDF in cervical cancer treatment, and enhance the current understanding of the antitumor properties of PEDF such as inhibiting angiogenesis and metastasis, inducing tumor cell apoptosis and differentiation, and modulating cellular immunity against cervical cancer. The production and delivery of PEDF, as well as derived short peptides and their respective receptors will also be discussed.
Export Options
About this article
Cite this article as:
J. Han and J. Guo , Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment, Current Molecular Medicine 2015; 15 (5) . https://dx.doi.org/10.2174/1566524015666150630124447
DOI https://dx.doi.org/10.2174/1566524015666150630124447 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery The p53-Mdm2 Pathway: Targets for the Development of New Anticancer Therapeutics
Mini-Reviews in Medicinal Chemistry The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
Current Pharmaceutical Design Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Pharmaceutical Perspectives of HECT-TYPE Ubiquitin Ligase Smurf1
Current Pharmaceutical Design Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma
Current Medicinal Chemistry Smart Biodecorated Hybrid Nanoparticles
Current Bionanotechnology (Discontinued) Uncommon Becoming Common: Case Series of Primary Fallopian Tube Cancers
Current Women`s Health Reviews Novel Analogues of CC-1065 and the Duocarmycins for the Use in Targeted Tumour Therapies
Anti-Cancer Agents in Medicinal Chemistry Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry Monoclonal Antibodies: A Prospective and Retrospective View
Current Medicinal Chemistry Signaling Pathways Underpinning the Manifestations of Ionizing Radiation-Induced Bystander Effects
Current Molecular Pharmacology Gemcitabine-Related Atrial Fibrillation: A Case Report and Review of the Literature
Current Drug Safety Lipid Based Nanosystems for Curcumin: Past, Present and Future
Current Pharmaceutical Design Melanoma Immunotherapy: Past, Present, and Future
Current Pharmaceutical Design A Link Between Chemical Structure and Biological Activity in Triterpenoids
Recent Patents on Anti-Cancer Drug Discovery Potential of Nanocarriers in Genetic Immunization
Recent Patents on Drug Delivery & Formulation Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects
Current Pharmaceutical Design